Skip to content

Predicting Normal vs. Carrier Status in Euploid Embryos of Translocation Carriers

Evaluation of the Accuracy of Predicting Normal or Carrier Status in Euploid Embryos Produced by Patients With Balanced Translocations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02178865
Enrollment
11
Registered
2014-07-01
Start date
2014-06-30
Completion date
2017-02-28
Last updated
2017-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balanced Chromosomal Translocation

Keywords

translocation

Brief summary

The purpose of this study is to assess the accuracy of predicting the normal or carrier status of human embryos resulting from in vitro-fertilization (IVF) from patients carrying a balanced translocation.

Detailed description

This study aims to evaluate the validity of using informative SNPs to distinguish balanced from normal embryos. This will involve acquiring material from families to set phase for informative SNPs, evaluation of existing and new embryo SNP array data, and follow up analysis of children born after applying the procedure.

Interventions

None listed

Sponsors

Reproductive Medicine Associates of New Jersey
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients with balanced translocations who have undergone IVF

Exclusion criteria

* those who do not wish to know their child(s) karyotype

Design outcomes

Primary

MeasureTime frame
Proportion of correct predictions of normal vs. balanced ploidy status as compared to conventional karyotypeup to 12 months once pregnant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026